<code id='CCCAF53796'></code><style id='CCCAF53796'></style>
    • <acronym id='CCCAF53796'></acronym>
      <center id='CCCAF53796'><center id='CCCAF53796'><tfoot id='CCCAF53796'></tfoot></center><abbr id='CCCAF53796'><dir id='CCCAF53796'><tfoot id='CCCAF53796'></tfoot><noframes id='CCCAF53796'>

    • <optgroup id='CCCAF53796'><strike id='CCCAF53796'><sup id='CCCAF53796'></sup></strike><code id='CCCAF53796'></code></optgroup>
        1. <b id='CCCAF53796'><label id='CCCAF53796'><select id='CCCAF53796'><dt id='CCCAF53796'><span id='CCCAF53796'></span></dt></select></label></b><u id='CCCAF53796'></u>
          <i id='CCCAF53796'><strike id='CCCAF53796'><tt id='CCCAF53796'><pre id='CCCAF53796'></pre></tt></strike></i>

          entertainment

          entertainment

          author:fashion    Page View:3
          Andrew Harnik/AP

          The Food and Drug Administration on Friday approved a new, rapid-acting medicine made by Sage Therapeutics to treat postpartum depression, the first oral treatment for the condition. But the agency denied the company’s application for an indication for major depression, a much larger potential market.

          The drug, which will be sold under the brand name Zurzuvae, is not meant to be taken chronically. Patients take it orally for 14 days. In two clinical trials, the drug was found to significantly improve depressive symptoms more than a placebo. The effect was maintained for four weeks after treatment.

          advertisement

          “Maternal mental health has been sidelined for far too long, but today’s approval of Zurzuvae helps to change that. Women have been waiting for an oral medicine that can specifically and rapidly improve the symptoms of PPD and we are proud to be able to deliver that,” said Barry Greene, Sage’s CEO, in a press release.

          Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

          GET STARTED Log In

          focus

          Bright Health sells Medicare Advantage business to Molina
          Bright Health sells Medicare Advantage business to Molina

          BrightHealthisofficiallyleavingthehealthinsurancemarket.ThecompanyhasagreedtosellitsMedicareAdvantag

          read more
          How the BIOSECURE Act is already affecting U.S., Chinese life science firms
          How the BIOSECURE Act is already affecting U.S., Chinese life science firms

          ARIANADREHSLER/AFPviaGettyImagesSANDIEGO— U.S.legislationthatseekstorestrictAmericanbiotechsfromwork

          read more
          Virginia high school admissions case could be legal follow
          Virginia high school admissions case could be legal follow

          3:24DemonstratorsprotestoutsideoftheSupremeCourtinWashington,Thursday,June29,2023,aftertheSupremeCou

          read more

          New report analyzes digital physical therapy solutions' effectiveness

          AdobeYou’rereadingthewebeditionofSTAT’sHealthTechnewsletter,ourguidetohowtechnologyistransformingthe